Essentiality of INH in TB Therapy

NCT01589497 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

NETWORK

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Rifampicin
DRUG: Isoniazid
DRUG: Pyrazinamide
DRUG: Ethambutol
DRUG: Moxifloxacin

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators

[object Object]